Employer Contracts Growth Dario recently signed four new employer contracts across its product suite, indicating a 35% growth in client base compared to the previous year. These contracts are expected to go live in the first quarter of 2025, offering a key sales opportunity to expand business-to-business-to-consumer (B2B2C) channels.

Pharma Collaboration Expansion Dario has expanded its collaborations with a global pharmaceutical leader, transitioning its business model to recurring service subscription fees. This significant shift aims to enhance user engagement with payors and pharmacy benefit managers, opening up avenues for further partnerships in the healthcare industry.

Medicaid Reach Expansion By signing a new contract with a regional health plan in the Medicaid space, Dario has extended its reach in the Medicaid population. This expansion marks immediate revenue contributions and presents a strategic sales opportunity to offer its cardiometabolic solutions to a broader audience.

Financial Performance Uptrend Dario reported strong improvements in financial performance in the third quarter of 2024, with a revenue increase of 18.7% over the previous quarter and a remarkable 111% growth compared to the same quarter last year. This positive financial trajectory showcases potential for sales growth and business expansion.

Pharma Partnership Initiative The collaboration with a top U.S. pharma client for a new drug to treat psoriasis presents a strategic initiative for Dario to onboard patients and enhance engagement through its platform services. This partnership signifies a vital sales opportunity to demonstrate the effectiveness of Dario's refined engagement and navigation technologies.